InfoBionic Closes $17M Series B Financing Round

infobionic-logoInfoBionic, Inc., a Lowell, MA-based digital health company focused on creating patient monitoring solutions for chronic disease management, closed its $17m Series B financing round.

It announced the first tranche of the Series B round in April 2014

New backers included Excel Venture Management and Zaffre Investments, which joined Safeguard Scientifics, Inc. (NYSE: SFE), Mass Medical Angels (MA2), Broadview Ventures, The Indus Entrepreneurs (TiE), Beta Fund, Launchpad Venture Group, Cherrystone, TCA, HTC, Boynton, and Keiretsu. In conjunction with the funding, Caleb Winder, Managing Director at Excel Venture Management, joined InfoBionic’s board of directors.

The company intends to use the funds to commercialize its MoMeTM System, a remote patient monitoring platform for cardiac arrhythmia detection, in Europe and the United States.

Led by Nancy Briefs, President, CEO and Co-Founder, and newly named Steven R. Wasserman (CFO) and William G. Swavely (Senior Vice President, IT), InfoBionic provides MoMe™ System, a cardiac arrhythmias event monitoring platform that makes it easier for patients to be diagnosed.




Join the discussion